Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients

References

• Hawthorne AB, Rubin G, Ghosh S. Medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalamine and other maintenance therapies. Aliment. Pharmacol. Ther.27, 1157–1166 (2008).
   PubMed Web of Science ®Google Scholar
• van Hees PA, van Tongeren JH. Compliance to therapy in patients on maintenance dose sulfasalazine. J. Clin. Gastroenterol.4(4), 333–336 (1982).
   PubMed Web of Science ®Google Scholar
• Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Gastroenterol.114, 39–34 (2003).
   Google Scholar
• Lee M, Kemp JA, Canning A et al. A randomized controlled trial of enhanced patient compliance program for Helicobacter pylori therapy. Arch. Intern. Med.159, 2312–2316 (1999).
   PubMed Web of Science ®Google Scholar
• Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther.27(Suppl. 1), 9–14 (2008).
   PubMed Web of Science ®Google Scholar
• Lakatos P. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it. World J. Gastroenterol.15, 4234–4239 (2009).
   PubMed Web of Science ®Google Scholar
• Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig. Dis. Sci.53(4), 1020–1024 (2008).
   PubMed Web of Science ®Google Scholar
• Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment. Pharmacol. Ther.23, 577–585 (2006).
   PubMed Web of Science ®Google Scholar
• Rubin DT, Siegel CA, Kane SV. The impact of ulcerative colitis from patients’ and physicians’ perspective: results from the UC: NORMAL survey. Inflamm. Bowel Dis.15, 581–588 (2009).
   PubMed Web of Science ®Google Scholar
• Kane SV, Cohen RD, Aikens JEB. Predictors of non-compliance with mesalamine in quiescent ulcerative colitis. Am. J. Gastroenterol.96, 2929–2932 (2001).
   PubMed Web of Science ®Google Scholar
• Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am. J. Gastroenterol.94, 1733–1742 (1999).
   PubMed Web of Science ®Google Scholar
• Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J. Clin. Gastroenterol.32(1), 66–68 (2001).
   PubMed Web of Science ®Google Scholar
• Kane S, Accortt N, Magowan S, Brixner D. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment. Pharmacol. Ther.29, 855–862 (2009).
   PubMed Web of Science ®Google Scholar
• Kane S, Sumner M, Solomon D, Jenkins M. Continuing persistence with mesalamine therapy: results from patients persistent with long-term therapy. Am. J. Gastroenterol.104(Suppl. 3), A1271 (2009).
   PubMedGoogle Scholar
• Kane S, Sumner M, Solomon D, Jenkins M. Factors affecting persistence with mesalamine therapy: results from a large pharmacy database. Am. J. Gastroenterol.104(Suppl. 3), A1272 (2009).
   Google Scholar
• Traynor K. Standards-setting group seeks to improve medication adherence. Am. J. Health Syst. Pharm.62, 2440–2442 (2005).
   PubMedGoogle Scholar
• Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog. Behav. Modif.28, 183–218 (1992).
   PubMedGoogle Scholar
• Tindall W, Boltri J, Wilhelp S. Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs. J. Manag. Care Pharm.13, S1–S12 (2007).
   Google Scholar
• Stewart MA. What is a successful doctor patient interview? A study of interactions and outcomes. Soc. Sci. Med.19, 167–175 (1984).
   PubMed Web of Science ®Google Scholar
• Fallowfield L, Jenkins V, Farewell V et al. Efficacy of a communication skills training model for oncologists: a randomized controlled trial. Lancet359, 650–656 (2002).
   PubMed Web of Science ®Google Scholar
• Morse DS, Edwardsen EA, Gordon HS. Missed opportunities for interval empathy in lung cancer communication. Arch. Intern. Med.168, 1853–1858 (2008).
   PubMed Web of Science ®Google Scholar
• Robinson A, Thompson DG, Wilkin D et al. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomized trial. Lancet358(9268), 976–981 (2001).
   PubMed Web of Science ®Google Scholar
• Tukey M, Flachuk K, Cheifetz A, Moss A. A patient support program (PSP) to enhance medication adherence and quality-of-life in patients prescribed mesalamine for ulcerative colitis – a pilot study. Am. J. Gastroenterol.73(Suppl.), A288 (2008).
   Google Scholar
• Dignass A, Bokemeyer B, Ademek H et al. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Clin. Gastroenterol. Hepatol.7, 762–769 (2009).
   PubMed Web of Science ®Google Scholar
• Prantera C, Viscido A, Biancone L et al. A new oral delivery system for 5-ASA: preliminary clinical findings for MMX. Inflamm. Bowel Dis.11, 421–427 (2005).
   PubMed Web of Science ®Google Scholar
• Gray J, Leung E, Scales J. Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapy. Aliment. Pharmacol. Ther.29, 1114–1120 (2009).
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am. J. Manag. Care15(1), 59–66 (2009).
   PubMed Web of Science ®Google Scholar
• Scherman MH, Lowhagen O. Drug compliance and identity: reasons for non-compliance. Experiences of medication from persons with asthma/allergy.Patient Educ. Couns.54, 3–9 (2004).
   PubMed Web of Science ®Google Scholar
• Yen EF, Kane SV, Ladabaum U. Cost–effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis. Am. J. Gastroenterol.103, 3094–3105 (2008).
   PubMedGoogle Scholar
• Higgins PD, Rubin DT, Kaulback K, Schoenfeld PS, Kane SV. Systematic review: impact of non-adherence to 5-ASA products on the frequency and cost of ulcerative colitis flares. Aliment. Pharmacol. Ther.29(3), 247–257 (2009).
   PubMed Web of Science ®Google Scholar
• Morisky DE, Alfonso A, Krousel-Wood M et al. Predicitve validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens.10, 348–354 (2008).
   PubMed Web of Science ®Google Scholar